Amare Teshome1, Aynishet Adane2, Biruk Girma1, Zeleke A Mekonnen3. 1. Department of Dentistry, School of Medicine, College of Medicine, and Health Science, University of Gondar, Gondar, Ethiopia. 2. Department of Internal Medicine, School of Medicine, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia. 3. College of Medicine and Health Science, Institute of Public Health, University of Gondar, Gondar, Ethiopia.
Abstract
Background: Coronavirus disease (COVID-19) is a respiratory and systemic disorder caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or novel Coronavirus (nCoV). To date, there is no proven curative treatment for this virus; as a result, prevention remains to be the best strategy to combat coronavirus infection (COVID-19). Vitamin D deficiency (VDD) has been proposed to play a role in coronavirus infection (COVID-19). However, there is no conclusive evidence on its impact on COVID-19 infection. Therefore, the present review aimed to summarize the available evidence regarding the association between Vitamin D levels and the risk of COVID-19 infection. Methods: A systematic literature search of databases (PUBMED/MEDLINE, Cochrane/Wiley library, Scopus, and SciELO) were conducted from May 15, 2020, to December 20, 2020. Studies that assessed the effect of vitamin D level on COVID-19/SARS-2 infection were considered for the review. The qualities of the included studies were evaluated using the JBI tools. Meta-analysis with a random-effects model was conducted and odds ratio with their 95%CI were reported. This systematic review and meta-analysis are reported according to the preferred reporting items for systematic review and meta-analysis (PRISMA) guideline. Results: The electronic and supplementary searches for this review yielded 318 records from which, only 14 of them met the inclusion criteria. The qualitative synthesis indicated that vitamin D deficient individuals were at higher risk of COVID-19 infection as compared to vitamin D sufficient patients. The pooled analysis showed that individuals with Vitamin-D deficiency were 80% more likely to acquire COVID-19 infection as compared to those who have sufficient Vitamin D levels (OR = 1.80; 95%CI: 1.72, 1.88). Begg's test also revealed that there was no significant publication bias between the studies (P = 0.764). The subgroup analysis revealed that the risk of acquiring COVID-19 infection was relatively higher in the case-control study design (OR = 1.81). Conclusions: In conclusion, low serum 25 (OH) Vitamin-D level was significantly associated with a higher risk of COVID-19 infection. The limited currently available data suggest that sufficient Vitamin D level in serum is associated with a significantly decreased risk of COVID-19 infection.
Background: Coronavirus disease (COVID-19) is a respiratory and systemic disorder caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or novel Coronavirus (nCoV). To date, there is no proven curative treatment for this virus; as a result, prevention remains to be the best strategy to combat coronavirus infection (COVID-19). Vitamin D deficiency (VDD) has been proposed to play a role in coronavirus infection (COVID-19). However, there is no conclusive evidence on its impact on COVID-19infection. Therefore, the present review aimed to summarize the available evidence regarding the association between Vitamin D levels and the risk of COVID-19infection. Methods: A systematic literature search of databases (PUBMED/MEDLINE, Cochrane/Wiley library, Scopus, and SciELO) were conducted from May 15, 2020, to December 20, 2020. Studies that assessed the effect of vitamin D level on COVID-19/SARS-2 infection were considered for the review. The qualities of the included studies were evaluated using the JBI tools. Meta-analysis with a random-effects model was conducted and odds ratio with their 95%CI were reported. This systematic review and meta-analysis are reported according to the preferred reporting items for systematic review and meta-analysis (PRISMA) guideline. Results: The electronic and supplementary searches for this review yielded 318 records from which, only 14 of them met the inclusion criteria. The qualitative synthesis indicated that vitamin D deficient individuals were at higher risk of COVID-19infection as compared to vitamin D sufficient patients. The pooled analysis showed that individuals with Vitamin-D deficiency were 80% more likely to acquire COVID-19infection as compared to those who have sufficient Vitamin D levels (OR = 1.80; 95%CI: 1.72, 1.88). Begg's test also revealed that there was no significant publication bias between the studies (P = 0.764). The subgroup analysis revealed that the risk of acquiring COVID-19infection was relatively higher in the case-control study design (OR = 1.81). Conclusions: In conclusion, low serum 25 (OH) Vitamin-D level was significantly associated with a higher risk of COVID-19infection. The limited currently available data suggest that sufficient Vitamin D level in serum is associated with a significantly decreased risk of COVID-19infection.
Authors: Micah D J Peters; Christina M Godfrey; Hanan Khalil; Patricia McInerney; Deborah Parker; Cassia Baldini Soares Journal: Int J Evid Based Healthc Date: 2015-09
Authors: Adrian R Martineau; David A Jolliffe; Richard L Hooper; Lauren Greenberg; John F Aloia; Peter Bergman; Gal Dubnov-Raz; Susanna Esposito; Davaasambuu Ganmaa; Adit A Ginde; Emma C Goodall; Cameron C Grant; Christopher J Griffiths; Wim Janssens; Ilkka Laaksi; Semira Manaseki-Holland; David Mauger; David R Murdoch; Rachel Neale; Judy R Rees; Steve Simpson; Iwona Stelmach; Geeta Trilok Kumar; Mitsuyoshi Urashima; Carlos A Camargo Journal: BMJ Date: 2017-02-15
Authors: Abdullah M Alguwaihes; Mohammed E Al-Sofiani; Maram Megdad; Sakhar S Albader; Mohammad H Alsari; Ali Alelayan; Saad H Alzahrani; Shaun Sabico; Nasser M Al-Daghri; Anwar A Jammah Journal: Cardiovasc Diabetol Date: 2020-12-05 Impact factor: 9.951
Authors: Claire E Hastie; Daniel F Mackay; Frederick Ho; Carlos A Celis-Morales; Srinivasa Vittal Katikireddi; Claire L Niedzwiedz; Bhautesh D Jani; Paul Welsh; Frances S Mair; Stuart R Gray; Catherine A O'Donnell; Jason Mr Gill; Naveed Sattar; Jill P Pell Journal: Diabetes Metab Syndr Date: 2020-05-07
Authors: Michael I McBurney; Jeffrey B Blumberg; Rebecca B Costello; Manfred Eggersdorfer; John W Erdman; William S Harris; Elizabeth J Johnson; Susan Hazels Mitmesser; Robert C Post; Deshanie Rai; Leon J Schurgers Journal: Nutrients Date: 2021-05-28 Impact factor: 5.717
Authors: Esmaeil Mortaz; Gillina Bezemer; Shamila D Alipoor; Mohammad Varahram; Sharon Mumby; Gert Folkerts; Johan Garssen; Ian M Adcock Journal: Front Nutr Date: 2021-07-05